Metabolomics & Lipidomics

Right now, we can only see small pieces of the colossal picture entitled “Food and Health”.

Performance-enhancing drug expert Douwe de Boer goes toe-to-toe with the Dutch Doping Authority’s Herman Ram on the big issues in sports doping.

How we go about the systematic study of the unique chemical fingerprints that specific cellular processes leave behind – and what we can learn from them.

The Windy City is set to welcome “the world’s largest annual premier conference and exposition on laboratory science”, but are you prepared? Here, we look at historical attendance trends and offer our top picks.

Where does clinical bio-molecular mass spectrometry (MS) sit on the steep slope between hype and hope?

Combining solid phase extraction with high-resolution accurate mass LC-MS increases sample throughput and improves detection and identification of nov

Despite a fall from grace in recent years, chemometrics has a key role to play in the interpretation of mega-variate datasets.

GC×GC provides simple improvements today and will be key to the personalized measurement devices of tomorrow.

Richard D. Smith reflects on 40 years in mass spectrometry following his Distinguished Contribution award at ASMS 2013.

An integrated approach to uncovering distinct metabolite profile shifts in diabetes progression. The prevalence of type 2 diabetes mellitus (T2DM) is on a rampant rise across the globe, making it a critical area of study for metabolomics and biomarker discovery.